I Sermet

Summary

Affiliation: University Hospitals Leuven
Country: Belgium

Publications

  1. ncbi Airway clearance techniques to treat acute respiratory disorders in previously healthy children: where is the evidence?
    Kris De Boeck
    Department of Paediatrics, University Hospital of Leuven, Herestraat 49, 3000 Leuven, Belgium
    Eur J Pediatr 167:607-12. 2008
  2. ncbi CFTR biomarkers: time for promotion to surrogate end-point
    K De Boeck
    University Hospital of Leuven, Leuven, Belgium
    Eur Respir J 41:203-16. 2013
  3. ncbi 'Difficult asthma': can symptoms be controlled in a structured environment?
    K De Boeck
    University Hospital Gasthuisberg, University of Leuven, Leuven, Belgium
    Pediatr Pulmonol 44:743-8. 2009
  4. ncbi Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN)
    K De Boeck
    Department of Pediatrics, University Hospital of Leuven, Leuven, Belgium
    J Cyst Fibros 10:S67-74. 2011
  5. ncbi New clinical diagnostic procedures for cystic fibrosis in Europe
    K De Boeck
    Department of Pediatrics, University Hospital of Leuven, Leuven, Belgium
    J Cyst Fibros 10:S53-66. 2011
  6. ncbi Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis
    C Goubau
    Department of Paediatrics, Paediatric Pulmonology, University Hospital of Leuven, Herestraat 49, 3000 Leuven, Belgium
    Thorax 64:683-91. 2009

Detail Information

Publications6

  1. ncbi Airway clearance techniques to treat acute respiratory disorders in previously healthy children: where is the evidence?
    Kris De Boeck
    Department of Paediatrics, University Hospital of Leuven, Herestraat 49, 3000 Leuven, Belgium
    Eur J Pediatr 167:607-12. 2008
    ..Physicians routinely prescribing airway clearance techniques in previously healthy children should question their practice...
  2. ncbi CFTR biomarkers: time for promotion to surrogate end-point
    K De Boeck
    University Hospital of Leuven, Leuven, Belgium
    Eur Respir J 41:203-16. 2013
    ..This body of work adds useful information to support the promotion of CFTR biomarkers to surrogate end-points and to guide further research in the area...
  3. ncbi 'Difficult asthma': can symptoms be controlled in a structured environment?
    K De Boeck
    University Hospital Gasthuisberg, University of Leuven, Leuven, Belgium
    Pediatr Pulmonol 44:743-8. 2009
    ..The objective was to evaluate children with difficult asthma in a setting that excludes aggravating factors such as poor treatment adherence and adverse environmental influences...
  4. ncbi Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN)
    K De Boeck
    Department of Pediatrics, University Hospital of Leuven, Leuven, Belgium
    J Cyst Fibros 10:S67-74. 2011
    ..A strong partnership with European CF patient parent organizations aims to increase awareness of the need for efficient clinical research and the participation of patients in clinical trials...
  5. ncbi New clinical diagnostic procedures for cystic fibrosis in Europe
    K De Boeck
    Department of Pediatrics, University Hospital of Leuven, Leuven, Belgium
    J Cyst Fibros 10:S53-66. 2011
    ..New approaches to evaluate the sweat gland, future of genetic testing and methods on the horizon like CFTR expression in human leucocytes and erythrocytes are discussed briefly...
  6. ncbi Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis
    C Goubau
    Department of Paediatrics, Paediatric Pulmonology, University Hospital of Leuven, Herestraat 49, 3000 Leuven, Belgium
    Thorax 64:683-91. 2009
    ....